Cargando…

Immunity and Viral Infections: Modulating Antiviral Response via CRISPR–Cas Systems

Viral infections cause a variety of acute and chronic human diseases, sometimes resulting in small local outbreaks, or in some cases spreading across the globe and leading to global pandemics. Understanding and exploiting virus–host interactions is instrumental for identifying host factors involved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brezgin, Sergey, Kostyusheva, Anastasiya, Bayurova, Ekaterina, Volchkova, Elena, Gegechkori, Vladimir, Gordeychuk, Ilya, Glebe, Dieter, Kostyushev, Dmitry, Chulanov, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310348/ https://www.ncbi.nlm.nih.gov/pubmed/34372578 http://dx.doi.org/10.3390/v13071373

Ejemplares similares

CRISPR Screening: Molecular Tools for Studying Virus–Host Interactions
por: Chulanov, Vladimir, et al.
Publicado: (2021)

CRISPR-Cas systems for diagnosing infectious diseases
por: Kostyusheva, Anastasiya, et al.
Publicado: (2022)

Replenishment of Hepatitis B Virus cccDNA Pool Is Restricted by Baseline Expression of Host Restriction Factors In Vitro
por: Brezgin, Sergey, et al.
Publicado: (2019)

ATM and ATR Expression Potentiates HBV Replication and Contributes to Reactivation of HBV Infection upon DNA Damage
por: Kostyusheva, Anastasiya, et al.
Publicado: (2019)

Clinical Implications of Hepatitis B Virus RNA and Covalently Closed Circular DNA in Monitoring Patients with Chronic Hepatitis B Today with a Gaze into the Future: The Field Is Unprepared for a Sterilizing Cure
por: Kostyusheva, Anastasiya, et al.
Publicado: (2018)

Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification
por: Kostyusheva, Anastasiya, et al.
Publicado: (2021)

Dead Cas Systems: Types, Principles, and Applications
por: Brezgin, Sergey, et al.
Publicado: (2019)

Suppressing the NHEJ pathway by DNA-PKcs inhibitor NU7026 prevents degradation of HBV cccDNA cleaved by CRISPR/Cas9
por: Kostyushev, Dmitry, et al.
Publicado: (2019)

Gene Editing by Extracellular Vesicles
por: Kostyushev, Dmitry, et al.
Publicado: (2020)

Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9
por: Kostyushev, Dmitry, et al.
Publicado: (2023)

Previous hepatitis B viral infection–an underestimated cause of pancreatic cancer
por: Batskikh, Sergey, et al.
Publicado: (2022)

Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus
por: Kostyushev, Dmitry, et al.
Publicado: (2023)

Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle–Mimetic Nanovesicles Loaded with Chemotherapeutics
por: Brezgin, Sergey, et al.
Publicado: (2023)

Clearing of Foreign Episomal DNA from Human Cells by CRISPRa-Mediated Activation of Cytidine Deaminases
por: Brezgin, Sergey, et al.
Publicado: (2020)

Common Marmoset Cell Lines and Their Applications in Biomedical Research
por: Bayurova, Ekaterina, et al.
Publicado: (2023)

Expression of the Reverse Transcriptase Domain of Telomerase Reverse Transcriptase Induces Lytic Cellular Response in DNA-Immunized Mice and Limits Tumorigenic and Metastatic Potential of Murine Adenocarcinoma 4T1 Cells
por: Jansons, Juris, et al.
Publicado: (2020)

HIV-1 Reverse Transcriptase Promotes Tumor Growth and Metastasis Formation via ROS-Dependent Upregulation of Twist
por: Bayurova, Ekaterina, et al.
Publicado: (2019)

Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G Expression
por: Kolesova, Ekaterina P., et al.
Publicado: (2023)

The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape
por: Darcis, Gilles, et al.
Publicado: (2019)

The Impact of CRISPR-Cas System on Antiviral Therapy
por: Bayat, Hadi, et al.
Publicado: (2018)

The Application of CRISPR/Cas Systems for Antiviral Therapy
por: Baddeley, Helen J. E., et al.
Publicado: (2021)

Nanomedicine for increasing the oral bioavailability of cancer treatments
por: Parodi, Alessandro, et al.
Publicado: (2021)

Defining the seed sequence of the Cas12b CRISPR-Cas effector complex
por: Jain, Ishita, et al.
Publicado: (2018)

CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
por: Chen, Shuliang, et al.
Publicado: (2018)

Epidemiology and Genotype Distribution of Hepatitis C Virus in Russia
por: Pimenov, Nikolay, et al.
Publicado: (2022)

Boosting plant immunity with CRISPR/Cas
por: Chaparro-Garcia, Angela, et al.
Publicado: (2015)

Editorial: CRISPR-Cas in Agriculture: Opportunities and Challenges
por: Kumar, Sandeep, et al.
Publicado: (2021)

CRISPR/Cas9 as an antiviral against Orthopoxviruses using an AAV vector
por: Siegrist, Cathryn M., et al.
Publicado: (2020)

CRISPR-Cas system: from diagnostic tool to potential antiviral treatment
por: Rajan, Aishwarya, et al.
Publicado: (2022)

CRISPR/Cas9-mediated viral interference in plants
por: Ali, Zahir, et al.
Publicado: (2015)

Cas9 specifies functional viral targets during CRISPR-Cas adaptation
por: Heler, Robert, et al.
Publicado: (2015)

Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems
por: Karpov, Dmitry S., et al.
Publicado: (2022)

Applications of CRISPR-Cas Technologies to Proteomics
por: Dolgalev, Georgii, et al.
Publicado: (2021)

HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells
por: Petkov, Stefan, et al.
Publicado: (2022)

Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3′-terminal segment of guide RNA
por: Mekler, Vladimir, et al.
Publicado: (2016)

CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients
por: Amini, Leila, et al.
Publicado: (2021)

CRISPR‐LbCas12a‐mediated modification of citrus
por: Jia, Hongge, et al.
Publicado: (2019)

CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge
por: Lee, Choongho
Publicado: (2019)

Application of CRISPR/Cas for Diagnosis and Management of Viral Diseases of Banana
por: Tripathi, Leena, et al.
Publicado: (2021)

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma
por: Kong, Huimin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pajieju81ej6k0fkrk25bb8hp8